Patent details
EP2806892 Title: COMBINED THERAPEUTIC USE OF ANTIBODIES AND ENDOGLYCOSIDASES
Basic Information
- Publication number:
- EP2806892
- PCT Application Number:
- GB2013050164
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP137018719
- PCT Publication Number:
- WO2013110946
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- COMBINED THERAPEUTIC USE OF ANTIBODIES AND ENDOGLYCOSIDASES
- French Title of Invention:
- TRAITEMENT COMBINÉ AVEC DES ANTICORPS ET DES ENDOGLYCOSIDASES
- German Title of Invention:
- KOMBINATIONSTHERAPIE MIT ANTIKÖRPERN UND ENDOGLYKOSIDASEN
- SPC Number:
Dates
- Filing date:
- 25/01/2013
- Grant date:
- 06/03/2019
- EP Publication Date:
- 03/12/2014
- PCT Publication Date:
- 01/08/2013
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 06/03/2019
- EP B1 Publication Date:
- 06/03/2019
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 25/01/2024
- Expiration date:
- 25/01/2033
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 12/10/2021
- Name:
- Hansa Biopharma Limited
- Address:
- Mount Manor House, 16 The Mount, GU2 4HN, Guildford, Surrey , United Kingdom (GB)
History of Owners
- From:
- 27/02/2019
- To:
- 12/10/2021
- Name:
- Immago Biosystems Ltd
- Address:
- Teme Place Teme Road, Cheltenham GL52 6UE, United Kingdom (GB)
Agent
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 05/06/2019
- Address:
- Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
- To:
Inventor
1
- Name:
- SCANLAN, Christopher Neil
- Address:
- United Kingdom (GB)
2
- Name:
- CRISPIN, Matthew David Max
- Address:
- United Kingdom (GB)
Priority
- Priority Number:
- 201201314
- Priority Date:
- 26/01/2012
- Priority Country:
- United Kingdom (GB)
Classification
- IPC classification:
- A61K 39/395; C07K 16/32; C12N 9/24;
Publication
Bulletin
- Bulletin Heading:
- CO
- Bulletin edition number:
- 2021/12
- Publication date:
- 04/11/2021
- Description:
- Section M : Transfers of property (Art. 53 of the law), change of name and/or address
European Patent Bulletin
- Issue number:
- 201910
- Publication date:
- 06/03/2019
- Description:
- Grant (B1)
Deed
Change of owner(s)
- Change Kind/ Decision Type:
- Change of owner(s) name/address
- Deed Number:
- RC20210000442A
- Date Registered:
- 12/10/2021
- Licence Effective Date:
- Licence Expiration Date:
- Scope of Licence:
- Deed Filer:
- OFFICE FREYLINGER S.A.
- Journal Edition Number:
- Text:
- Change of owners name and address
- Country Code:
- Updated Licence Number:
- Terminated Licence Number:
Added Owner(s)
- Name:
- Hansa Biopharma Limited
- Address:
- Mount Manor House, 16 The Mount, GU2 4HN, Guildford, Surrey , United Kingdom (GB)
Removed Pledgee
- Name:
- Address:
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- 13/01/2023
- Last Annual Fee Paid Number:
- 11
- Last Annual Fee Paid Amount:
- 148 Euro
- Payer:
- CPA GLOBAL THE IP PLATFORM
| Filing date | Document type | Number of pages |
|---|---|---|
| 05/06/2019 | Power Of Attorney | 1 |
| 12/10/2021 | Request For Change | 5 |
| 19/06/2019 | Outgoing Correspondence | 1 |
| 12/10/2021 | Outgoing Correspondence | 1 |